Patients with heart failure or…

The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the…

Patients with a history of atrial fibrillation (AFib) are more likely to experience adverse outcomes within two years of transcatheter aortic valve…

When the first catheter-implanted, leadless pacemaker was introduced in 2016, there was a lot of interest in this minimally invasive technology. But the biggest criticism was that it only addressed the needs of about 20% of patients. However, 100…

Catheter ablation is an "economically attractive" treatment option for atrial fibrillation (AFib) when compared to antiarrhythmic drug therapy alone,, according to a new study in Circulation.[1] 

While the lifetime cost of…

Patients who develop atrial fibrillation (AFib) after surgery face a higher risk of being hospitalized for heart failure, according to new data published in the European Heart Journal.[1]

The study’s authors tracked data from…

Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller…

Marijuana use among older adults is associated with a heightened risk of atrial and ventricular arrhythmias, according to new research published in the American Journal of Cardiology.[1]

“Marijuana is widely used across the…

Non-vitamin K antagonist oral anticoagulants (NOACs) may be a safe alternative to warfarin when treating patients with atrial fibrillation (AFib) and valvular heart disease (VHD), according to new research published in the American Journal of…

inHEART Medical, an international healthcare company with offices in France and the United States, has received clearance from the U.S. Food and Drug Administration (FDA) for its new 3D visualization software…

Left bundle branch block (LBBB), one of the most common complications after transcatheter aortic valve replacement (TAVR), is associated with worse…

It has been a busy few weeks for the U.S. Food and Drug Administration (FDA). The agency…

Atrial fibrillation patients who underwent left atrial appendage occlusion (LAAO) with the Watchman device after it gained U.S. FDA approval have experienced fewer complications and faced a lower risk of ischemic stroke than patients included in…

A late-breaking study found epicardial ablation in Brugada syndrome (BrS) helped significantly reduce sudden cardiac arrest in these patients, increasing…

Cardiologist Morton M. Mower, MD, co-inventor of the automatic implantable cardioverter defibrillator (ICD), has died of cancer. He was 89 years old.

The Baltimore Sun published a heartfelt tribute to the doctor, noting that Mower…

Same-day discharge (SDD) is an effective treatment option for patients undergoing atrial fibrillation (AFib) ablation, according to new findings presented at Heart Rhythm 2022.

The study’s authors…

The U.S. Food and Drug Administration (FDA) has approved mavacamten, sold by Bristol Myers Squibb (BMS) under the name Camzyos, for the treatment of adult patients with…

Same-day discharge (SDD) after left atrial appendage occlusion (LAAO) is a safe treatment option that does not lead to worse patient outcomes, according to new findings published in the American Journal of Cardiology.[1]

The…

Using drones to deliver automated external defibrillators (AEDs) is an effective way to reach patients suffering from out-of-hospital cardiac arrest (OHCA), according to a new analysis published in European Heart Journal.[1]

In…